Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS (Details Narrative)

v3.22.2.2
ACQUISITIONS (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 01, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Business Acquisition [Line Items]            
Weighted-average amortization period       3 years    
Revenue   $ 33,723,000 $ 38,304,000 $ 106,292,000 $ 102,137,000  
Difference between actual revenue and pro forma revenue   33,723,000 38,304,000 106,292,000 119,929,000  
medSR [Member]            
Business Acquisition [Line Items]            
Earnout, payment $ 13,000,000          
Fair value of contingent consideration 5,600,000 200,000   200,000   $ 3,100,000
Consideration paid 1,500,000          
Revenue and backlog milestones, payments $ 500,000          
Additional shares held, terms 18 months          
Escrow, settlement     250,000      
Working capital, adjustment     $ 250,000   250,000  
Escrow, deposit held       71,000    
Escrow, deposit   1,000,000   1,000,000   $ 1,000,000
Cash   12,300,000   $ 12,300,000    
Weighted-average amortization period       3 years    
Revenue   $ 6,400,000   $ 22,200,000    
Difference between actual revenue and pro forma revenue         $ 17,800,000  
Asset and Stock Purchase Agreement [Member] | MedMatica [Member]            
Business Acquisition [Line Items]            
Consideration paid $ 10,000,000          
Working capital deficiency 3,800,000          
Maximum earn-out payments based upon achievements 8,000,000          
Additional maximum earn-out payments based upon achievements $ 5,000,000